Clinical Global Impression of Cariprazine in Negative Symptom Schizophrenia Patients: Comparison of clinical trial data vs. real-world evidence von Rancans, E., Dombi, Z. B., Csehi, R., Németh, G.

Volltext

The Role of Partial Agonists and Specifically Cariprazine in Dual Disorders von Barabássy, Á, Dombi, Z B, Csehi, R, Djuric, D, Németh, G

Volltext

Predominant negative symptoms: views of patients vs. doctors in a 1-year observational study von Dragasek, J, Dombi, Z B, Acsai, K, Dzurilla, V, Barabássy, Á

Volltext

Relapse prevention with cariprazine in patients with early-stage schizophrenia von Correll, C U, Dombi, Z B, Herman, P L, Barabássy, Á

Volltext

Safety during polypharmacy: A post-hoc analysis examining the safety profile of cariprazine with other antipsychotics in the cross-titration phase von Vass, G., Barabássy, Á., Laszlovszky, I., Sebe, B., Dombi, Z.B., Szatmári, B., Németh, G.

Volltext

Tolerability of cariprazine in the early stage of schizophrenia: A pooled, post-hoc analysis of 4 phase ii/iii double-blind placebo-controlled trials von Dombi, Z.B., Acsai, K., Barabássy, Á., Sebe, B., Laszlovszky, I., Vass, G., Szatmári, B., Patel, M., Earley, W., Németh, G.

Volltext

The effect of cariprazine on patient engagement: Post-hoc analysis of a phase 3 study in patients with predominant negative symptoms of schizophrenia von Laszlovszky, I., Dombi, Z.B., Balogh, Á., Barabássy, Á., Vass, G., Szatmári, B., Németh, G.

Volltext

Light-field-driven current control in solids with pJ-level laser pulses at 80 MHz repetition rate von Hanus, V, Csajbók, V, Pápa, Z, Budai, J, Márton, Z, Kiss, G.Z, Sándor, P, Paul, P, Szeghalmi, A, Wang, Z, Bergues, B, Kling, M.F, Molnár, G, Volk, J, Dombi, P

Volltext bestellen